48.36
price down icon4.16%   -2.10
after-market アフターアワーズ: 48.70 0.34 +0.70%
loading
前日終値:
$50.46
開ける:
$50.72
24時間の取引高:
2.24M
Relative Volume:
0.78
時価総額:
$9.12B
収益:
$2.83B
当期純損益:
$-1.02B
株価収益率:
-8.7768
EPS:
-5.51
ネットキャッシュフロー:
$194.14M
1週間 パフォーマンス:
-10.94%
1か月 パフォーマンス:
-8.79%
6か月 パフォーマンス:
-10.87%
1年 パフォーマンス:
+3.31%
1日の値動き範囲:
Value
$48.32
$50.77
1週間の範囲:
Value
$48.32
$54.85
52週間の値動き範囲:
Value
$39.97
$72.83

Exact Sciences Corp Stock (EXAS) Company Profile

Name
名前
Exact Sciences Corp
Name
セクター
Healthcare (1161)
Name
電話
608-284-5700
Name
住所
5505 ENDEAVOR LANE, MADISON, WI
Name
職員
7,000
Name
Twitter
@exactsciences
Name
次回の収益日
2024-11-05
Name
最新のSEC提出書
Name
EXAS's Discussions on Twitter

EXAS を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Diagnostics & Research icon
EXAS
Exact Sciences Corp
48.36 10.24B 2.83B -1.02B 194.14M -5.51
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
404.94 160.56B 42.90B 6.52B 6.72B 17.05
Diagnostics & Research icon
DHR
Danaher Corp
188.07 141.52B 23.82B 3.77B 4.90B 5.15
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
520.87 42.74B 3.93B 894.97M 837.70M 10.82
Diagnostics & Research icon
A
Agilent Technologies Inc
112.04 34.11B 6.63B 1.17B 1.19B 4.05
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
158.96 27.70B 15.50B 1.33B 2.16B 7.34

Exact Sciences Corp Stock (EXAS) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-04-10 開始されました Mizuho Outperform
2025-03-13 開始されました RBC Capital Mkts Sector Perform
2025-01-23 開始されました Barclays Overweight
2024-08-28 開始されました Wells Fargo Overweight
2024-06-27 開始されました Scotiabank Sector Outperform
2024-06-03 再開されました Jefferies Buy
2024-01-02 アップグレード The Benchmark Company Hold → Buy
2023-12-14 開始されました Guggenheim Buy
2023-12-13 開始されました Wolfe Research Outperform
2023-10-10 アップグレード Piper Sandler Neutral → Overweight
2023-09-28 開始されました Bernstein Outperform
2023-08-02 ダウングレード The Benchmark Company Buy → Hold
2023-05-10 アップグレード Craig Hallum Hold → Buy
2023-05-05 開始されました UBS Neutral
2023-03-09 アップグレード Citigroup Neutral → Buy
2023-02-10 ダウングレード Credit Suisse Outperform → Neutral
2023-01-18 ダウングレード Raymond James Outperform → Mkt Perform
2022-10-19 ダウングレード Craig Hallum Buy → Hold
2022-08-25 開始されました Credit Suisse Outperform
2022-06-03 開始されました Piper Sandler Neutral
2021-11-03 ダウングレード Raymond James Strong Buy → Outperform
2021-07-29 繰り返されました BTIG Research Buy
2021-07-29 繰り返されました Canaccord Genuity Buy
2021-07-29 繰り返されました Oppenheimer Outperform
2021-07-29 繰り返されました Stifel Buy
2021-06-15 開始されました Raymond James Strong Buy
2021-06-03 開始されました Goldman Buy
2021-05-25 開始されました Wells Fargo Equal Weight
2021-01-28 開始されました Truist Buy
2020-10-29 ダウングレード UBS Buy → Neutral
2020-10-28 ダウングレード Citigroup Buy → Neutral
2020-10-08 再開されました BTIG Research Buy
2020-04-02 開始されました Evercore ISI Outperform
2020-01-10 再開されました BTIG Research Buy
2020-01-07 開始されました Citigroup Buy
2019-12-13 開始されました Dougherty & Company Buy
2019-11-15 開始されました Stifel Buy
2019-10-17 繰り返されました BofA/Merrill Buy
2019-10-01 再開されました Craig Hallum Buy
2019-09-26 開始されました Oppenheimer Outperform
2019-02-26 アップグレード Goldman Neutral → Buy
2018-10-09 開始されました UBS Buy
2018-09-05 再開されました The Benchmark Company Hold
2018-08-13 繰り返されました Canaccord Genuity Buy
2018-04-03 アップグレード BTIG Research Neutral → Buy
2018-01-29 開始されました Goldman Neutral
2018-01-08 繰り返されました The Benchmark Company Buy
2017-11-13 ダウングレード Robert W. Baird Outperform → Neutral
2017-11-01 ダウングレード BTIG Research Buy → Neutral
すべてを表示

Exact Sciences Corp (EXAS) 最新ニュース

pulisher
09:02 AM

U.S. Biomarkers Market Projected to Surpass USD 106.03 Billion by 2034 | CAGR: 15.6% - industrytoday.co.uk

09:02 AM
pulisher
Jul 20, 2025

What analysts say about Exact Sciences Corporation stockExplosive wealth accumulation - PrintWeekIndia

Jul 20, 2025
pulisher
Jul 20, 2025

What drives Exact Sciences Corporation stock priceBreakthrough investment results - PrintWeekIndia

Jul 20, 2025
pulisher
Jul 19, 2025

How to Invest in Financial Technology Stocks Strategic Stock Investment PlanFree Trend-Following Techniques - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 19, 2025

Is Exact Sciences Corporation a good long term investmentAccelerated earnings growth - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 18, 2025

Top Stocks for Wealth Management AI Powered Stock Selection StrategyHigh-performance investment picks - jammulinksnews.com

Jul 18, 2025
pulisher
Jul 18, 2025

Thermo Fisher, Exact Sciences, Integer Holdings, Revvity, and 10x Genomics Shares Are Falling, What You Need To Know - Yahoo Finance

Jul 18, 2025
pulisher
Jul 18, 2025

Canaccord Genuity reiterates Buy rating on Exact Sciences stock ahead of study - Investing.com

Jul 18, 2025
pulisher
Jul 18, 2025

Envestnet Asset Management Inc. Buys 13,004 Shares of Freshpet, Inc. (NASDAQ:FRPT) - Defense World

Jul 18, 2025
pulisher
Jul 15, 2025

Wall Street Analysts Think Exact Sciences (EXAS) Could Surge 26.24%: Read This Before Placing a Bet - Yahoo Finance

Jul 15, 2025
pulisher
Jul 14, 2025

Exact Sciences to release Q2 2025 results on August 6 By Investing.com - Investing.com Canada

Jul 14, 2025
pulisher
Jul 14, 2025

Exact Sciences to release Q2 2025 results on August 6 - Investing.com Australia

Jul 14, 2025
pulisher
Jul 14, 2025

Press Release: Exact Sciences Schedules Second Quarter 2025 Earnings Call - 富途牛牛

Jul 14, 2025
pulisher
Jul 14, 2025

Exact Sciences Schedules Second Quarter 2025 Earnings Call - The Globe and Mail

Jul 14, 2025
pulisher
Jul 11, 2025

EXAS SEC FilingsExact Sciences Corp 10-K, 10-Q, 8-K Forms - Stock Titan

Jul 11, 2025
pulisher
Jul 10, 2025

Exact Sciences stock rises as Canaccord maintains Buy rating By Investing.com - Investing.com Canada

Jul 10, 2025
pulisher
Jul 10, 2025

Exact’s Cancer-Screening Patent Invalidated in Geneoscopy Win - Bloomberg Law News

Jul 10, 2025
pulisher
Jul 10, 2025

Geneoscopy Wins Patent Trial and Appeal Board Decision, Invalidating All 20 Claims of Exact Sciences’ ’781 Patent - Business Wire

Jul 10, 2025
pulisher
Jul 10, 2025

August 29th Options Now Available For EXACT Sciences Corp. (EXAS) - Nasdaq

Jul 10, 2025
pulisher
Jul 10, 2025

Exact Sciences stock rises as Canaccord maintains Buy rating - Investing.com

Jul 10, 2025
pulisher
Jul 09, 2025

Exact Sciences’ Oncodetect test receives Medicare coverage By Investing.com - Investing.com Nigeria

Jul 09, 2025
pulisher
Jul 09, 2025

Exact Sciences Says Its Oncodetect Test to Detect Colorectal Cancer Gets Medicare Coverage - MarketScreener

Jul 09, 2025
pulisher
Jul 09, 2025

Exact Sciences’ Oncodetect test receives Medicare coverage - Investing.com Australia

Jul 09, 2025
pulisher
Jul 09, 2025

Exact Sciences announces Medicare coverage for Oncodetect(TM) molecular residual disease - MarketScreener

Jul 09, 2025
pulisher
Jul 09, 2025

Exact Sciences gains Medicare coverage for colorectal cancer test - StreetInsider

Jul 09, 2025
pulisher
Jul 09, 2025

Exact Sciences Announces Medicare Coverage for Oncodetect™ Molecular Residual Disease Test in Colorectal Cancer - Business Wire

Jul 09, 2025
pulisher
Jul 07, 2025

What Makes Exact Sciences (EXAS) a New Buy Stock - Yahoo Finance

Jul 07, 2025
pulisher
Jul 03, 2025

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar - Yahoo Finance

Jul 03, 2025
pulisher
Jul 02, 2025

Tom Still: Cancer tests continue to propel Exact Sciences - ehextra.com

Jul 02, 2025
pulisher
Jun 30, 2025

Concerns Rise Over Exact Sciences Corp. (EXAS) Salesforce Reorganization Affecting Growth - Yahoo Finance

Jun 30, 2025
pulisher
Jun 27, 2025

EXAS Shares Gain as Supreme Court Decision Clarifies Market Concerns | EXAS Stock News - GuruFocus

Jun 27, 2025
pulisher
Jun 27, 2025

Exact Sciences (EXAS) Sees Positive Impact from Supreme Court Decision | EXAS Stock News - GuruFocus

Jun 27, 2025
pulisher
Jun 27, 2025

Gilead shares rise after US top court ruling on preventive coverage - Reuters

Jun 27, 2025
pulisher
Jun 26, 2025

The 5 Most Interesting Analyst Questions From Exact Sciences’s Q1 Earnings Call - Yahoo Finance

Jun 26, 2025
pulisher
Jun 25, 2025

Could Personalized Medicine Be Your Portfolio's Next Big Winner? Find Out - Benzinga

Jun 25, 2025
pulisher
Jun 24, 2025

EXAS: Barclays Adjusts Price Target for Exact Sciences | EXAS Stock News - GuruFocus

Jun 24, 2025
pulisher
Jun 24, 2025

QGEN vs. EXAS: Which Stock Is the Better Value Option? - Yahoo Finance

Jun 24, 2025
pulisher
Jun 23, 2025

Barclays Adjusts Price Target for Exact Sciences (EXAS) in Q2 Ou - GuruFocus

Jun 23, 2025
pulisher
Jun 23, 2025

Exact Sciences Expands Oncodetect Validation, Unveils MRD Innovation Roadmap. - Yahoo Finance

Jun 23, 2025
pulisher
Jun 19, 2025

Inside Wisconsin: Cancer tests continue to propel Exact Sciences, even in a skeptical age - hngnews.com

Jun 19, 2025
pulisher
Jun 18, 2025

Exact Sciences in Madison unveils trio of cancer detection tests - The Cap Times

Jun 18, 2025
pulisher
Jun 17, 2025

Tom Still: Cancer tests continue to propel Exact Sciences, even in time of research cuts - La Crosse Tribune

Jun 17, 2025
pulisher
Jun 16, 2025

Insider Sell: Katherine Zanotti Sells Shares of Exact Sciences Corp (EXAS) - GuruFocus

Jun 16, 2025
pulisher
Jun 16, 2025

Exact Sciences Shareholders Approve New Incentive Plan By Investing.com - Investing.com Canada

Jun 16, 2025
pulisher
Jun 16, 2025

Exact Sciences Shareholders Approve New Incentive Plan - Investing.com

Jun 16, 2025
pulisher
Jun 12, 2025

Exact Sciences Corp (EXAS) Shares Gap Down to $53.95 on Jun 12 - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

Molecular Diagnostics for Cancer Market Research 2025: Advances in Personalized Medicine and Liquid Biopsies Reshape Industry Landscape - GlobeNewswire Inc.

Jun 12, 2025
pulisher
Jun 11, 2025

Colorectal Cancer Screening Market Deep Research Report - openPR.com

Jun 11, 2025
pulisher
Jun 10, 2025

Rhumbline Advisers Acquires 3,873 Shares of Exact Sciences Co. (NASDAQ:EXAS) - Defense World

Jun 10, 2025
pulisher
Jun 09, 2025

Hologic Climbs 13% in a Month: How Should You Play the Stock? - Yahoo Finance

Jun 09, 2025
pulisher
Jun 09, 2025

Exact Sciences Co. (NASDAQ:EXAS) Stock Position Increased by GAMMA Investing LLC - Defense World

Jun 09, 2025

Exact Sciences Corp (EXAS) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
diagnostics_research WAT
$281.66
price down icon 2.04%
diagnostics_research DGX
$166.45
price down icon 0.28%
$140.63
price up icon 1.25%
diagnostics_research LH
$243.04
price down icon 0.28%
diagnostics_research MTD
$1,166.48
price down icon 2.37%
diagnostics_research IQV
$158.96
price down icon 1.04%
大文字化:     |  ボリューム (24 時間):